Biotron Limited
BITRF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.49 | 1.23 | -0.49 | 1.17 |
| FCF Yield | -3.93% | -7.26% | -14.71% | -5.49% |
| EV / EBITDA | -40.53 | -13.92 | -5.12 | -15.63 |
| Quality | ||||
| ROIC | -61.38% | 1,479.96% | -112.12% | -233.35% |
| Gross Margin | 100.00% | 97.54% | 96.97% | 97.10% |
| Cash Conversion Ratio | 1.78 | 1.04 | 0.94 | 0.88 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.21% | 1.82% | -0.70% | 214.71% |
| Free Cash Flow Growth | 84.06% | -8.47% | -35.06% | 28.63% |
| Safety | ||||
| Net Debt / EBITDA | 2.79 | 0.11 | 1.09 | 0.61 |
| Interest Coverage | 0.00 | -3,228.42 | -822.06 | -549.82 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -2,573.34 | -2,401.91 | -2,507.80 |